Janux Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.33 | -$0.33 | -$0.33 |
| Q2 2024 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q3 2024 | 2 | -$0.33 | -$0.33 | -$0.33 |
| Q4 2024 | 6 | -$0.44 | -$0.32 | -$0.39 |
| Q1 2025 | 4 | -$0.44 | -$0.31 | -$0.39 |
| Q2 2025 | 2 | -$0.41 | -$0.41 | -$0.41 |
| Q3 2025 | 2 | -$0.44 | -$0.44 | -$0.44 |
| Q4 2025 | 2 | -$0.46 | -$0.46 | -$0.46 |
| Q1 2026 | 1 | -$0.32 | -$0.32 | -$0.32 |
| Q2 2026 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q3 2026 | 1 | -$0.37 | -$0.37 | -$0.37 |
| Q4 2026 | 1 | -$0.43 | -$0.43 | -$0.43 |
Janux Therapeutics, Inc. Earnings Date And Information
Janux Therapeutics, Inc. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $-0.51 earnings per share for the quarter, missing analysts' consensus estimates of $-0.37 by $0.14. The company had revenue of 439,000 for the quarter and had revenue of 8.08 M for the year. Janux Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-1.32 diluted earnings per share) and currently has a price-to-earnings ratio of -43.24. Janux Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 7th, 2025 based on prior year's report dates.
Janux Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2024 | Q3 2024 | -$0.37 | -$0.51 | -0.14 | $1.50 M | $439,000 |
| 08/07/2024 | Q2 2024 | -$0.32 | -$0.11 | 0.21 | $772,000 | $8.90 M |
| 05/07/2024 | Q1 2024 | -$0.30 | $1.25 M | |||
| 03/08/2024 | Q4 2023 | -$0.37 | -$0.25 | 0.12 | $2.46 M | |
| 11/07/2023 | Q3 2023 | -$0.46 | -$0.25 | 0.21 | $845,500 | $2.52 M |
| 08/08/2023 | Q2 2023 | -$0.52 | -$0.42 | 0.1 | $875,000 | $1.06 M |
| 05/09/2023 | Q1 2023 | -$0.49 | -$0.42 | 0.07 | $2.05 M | |
| 03/10/2023 | Q4 2022 | -$0.45 | -$0.27 | 0.18 | $2.85 M | |
| 11/10/2022 | Q3 2022 | -$0.51 | -$0.34 | 0.17 | $742,583 | $1.81 M |
| 08/09/2022 | Q2 2022 | -$0.37 | -$0.40 | -0.03 | $650,000 | $2.37 M |
| 05/10/2022 | Q1 2022 | -$0.37 | -$0.32 | 0.05 | $1.59 M | |
| 03/18/2022 | Q4 2021 | -$0.30 | -$0.33 | -0.03 | $1.62 M | |
| 11/09/2021 | Q3 2021 | -$0.17 | -$0.26 | -0.09 | $133,333 | $1.16 M |
| 08/10/2021 | Q2 2021 | -$0.13 | -$0.62 | -0.49 | $133,333 | $482,000 |
| 03/30/2021 | Q1 2021 | -$0.06 | $380,000 | |||
| 12/30/2020 | Q4 2020 | -$0.13 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.10 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.20 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.11 | $0 |
Janux Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Janux Therapeutics, Inc.'s earnings date?
Janux Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 7th, 2025 based off last year's report dates.
-
How can I listen to Janux Therapeutics, Inc.'s earnings conference call?
The conference call for Janux Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Janux Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Janux Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Janux Therapeutics, Inc. generate each year?
Janux Therapeutics, Inc. (:JANX) has a recorded annual revenue of $8.08 M.
-
How much profit does Janux Therapeutics, Inc. generate each year?
Janux Therapeutics, Inc. (:JANX) has a recorded net income of $8.08 M. Janux Therapeutics, Inc. has generated $-1.32 earnings per share over the last four quarters.
-
What is Janux Therapeutics, Inc.'s price-to-earnings ratio?
Janux Therapeutics, Inc. (:JANX) has a price-to-earnings ratio of -43.24 and price/earnings-to-growth ratio is 1.51.
